|
|
| |
| |
 |
What is Merial's business? |
|
| |
|
What is Merial's vision? |
|
| |
|
When was Merial founded? |
|
| |
|
How many people are employed by Merial? |
|
| |
|
What are Merial's total sales? |
|
| |
|
Who leads Merial's senior management team? |
|
| |
|
Who are Merial's shareholders? |
|
| |
|
Does Merial have a stock market listing? |
|
| |
|
In which countries does Merial operate? |
|
| |
|
What is Merial's main customer base? |
|
| |
|
What is Merial's R & D focus? |
|
| |
| |
Q. |
What is Merial's business? |
|
| |
A. |
Merial is an innovation-driven leader in the provision of products and solutions that enhance the health, well-being and performance of animals.
|
|
 |
| |
Q. |
What is Merial's vision? |
|
| |
A. |
Merial will be the recognized benchmark in providing value to our customers, employees and shareholders.
|
|
|
| |
Q. |
When was Merial founded? |
|
| |
A. |
Merial was founded in August 1997 through the merger of the animal health businesses of Merck and Co., Inc. and Rhone Merieux, a predecessor to sanofi-aventis.
|
|
|
| |
Q. |
How many people are employed by Merial? |
|
| |
A. |
Merial employs approximately 5,700 people worldwide.
|
|
|
| |
Q. |
What are Merial's total sales? |
|
| |
A. |
Total 2008 sales were nearly $2.6 billion.
|
|
|
| |
Q. |
Who leads Merial's senior management team? |
|
| |
A. |
Jose Barella is the Executive Chairman.
|
|
|
| |
Q. |
Who are Merial's shareholders? |
|
| |
A. |
Merial is the Animal Health subsidiary of sanofi-aventis.
|
|
|
| |
Q. |
Does Merial have a stock market listing? |
|
| |
A. |
No. Merial is a subsidiary of sanofi-aventis, which is listed on the Paris Stock Exchange.
|
|
|
| |
Q. |
In which countries does Merial operate? |
|
| |
A. |
Merial operates in more than 150 countries worldwide. See www.merial.com for a listing of countries.
|
|
|
| |
Q. |
What is Merial's main customer base? |
|
| |
A. |
Merial’s customers include veterinarians, pet owners, farmers and food animal producers worlwide.
|
|
|
| |
Q. |
What is Merial's R & D focus? |
|
| |
A. |
Merial is advancing in four main areas: parasiticides, antibiotics, pain control, and products for treating chronic conditions in companion animals. We are also exploring and developing new ranges of vaccines which employ both conventional and novel technologies with the objective of offering enhanced protection to a wide range of animal species.
|
|
|
